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Abstract
Tissue localization of a subcomponent of the first component of complement (CLq) was ex-
amined in one postmortem case of HBs antigen (HBs Ag) positive hepatocellular carcinoma and in
six cases of chronic hepatitis from liver biopsy specimens. The direct immunofluorescent method
was used after fixation with 2% para-formaldehyde in concentrated ammonium sulfate. CLq lo-
calization was found in collagen fibers and the cytoplasm of fibroblasts in the connective tissues of
specimens examined. The localization was particularly marked in the region of the fundal glands
of the gastric wall. Apart from collagen fibers, other sites of localization included the surface
membrane of lymphocytes, especially those cells of the mesenteric lymph nodes. In HBs Ag pos-
itive specimens, immune deposit-like substances appeared localized intra-hepatically and in the
renal glomeruli. Since C3 and C4 were identified concomitantly, it indicates that these substances
were indeed immune diposits. Despite the finding that C3 and C4 were identified together in the
hepatic cell cytoplasm, C1q itself was not demonstrated in all hepatic cell cytoplasms.
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A.bstract. Tissue localization of a subcomponent of the first com-
ponent of complement (Clq) was examined in one postmortem case of
HBs antigen (HBs Ag) positive hepatocellular carcinoma and in six
cases of chronic hepatitis from liver biopsy specimens. The direct im-
munofluorescent method was used after fixation with 2% para-formalde-
hyde in concentrated ammonium sulfate. Clq localization was found
in collagen fibers and the cytoplasm of fibroblasts in the connective
tissues of specimens examined. The localization was particularly
marked in the region of the fundal glands of the gastric wall. Apart
from collagen fibers, other sites of localization included the surface
membrane of lymphocytes, especially those cells of the mesenteric
lymph nodes. In HBs Ag positive specimens, immune deposit-like
substances appeared localized intra-hepatically and in the renal glo-
meruli. Since C3 and C4 were identified concomitantly, it indicates
that these substances were indeed immune deposits. Despite the find-
ing that C3 and C4 were identified together in the hepatic cell cyto-
plasm, Clq itself was not demonstrated in all hepatic cell cytoplasms.
A subcomponent of the first component of complement (Clq) (I) has re-
cently been used as a reagent in the radioimmunologic method for detection of
immune complexes in serum or other biologic fluids of various autoimmune dis-
eases (2-5\ It is postulated, however, that the progressive liver damage of chron-
ic hepatitis type B may be due to an autoimmune reaction directed against the
hepatocyte surface lipoprotein initiated by a hepatitis B virus (HBV) infection
(6-9); but the localization of Clq in the liver tissue during chronic hepatitis type
B and the precise role of the autoimmune mechanism in progressive liver damage
are not yet clear (8,9). With the object of clarifying the localization of Clq in
the liver of chronic hepatitis type B and in other organs and tissues of man,
the present authors used the direct immunofluorescent technique to examine
this problem.
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MATERIALS AND METHODS
Research specimens were prepared from frozen tissues of the liver, kidney,
spleen, mesenteric lymph nodes, stomach, and small intestine of an autopsy case
of hepatocellular carcinoma with hepatic cirrhosis. The serum was BBs anti-
gen (BBs Ag) positive (immunoelectrophoretic method) (10) and alpha-fetopro-
tein positive Iradioimmunoassay 1.3 X 104 ng/ml).
Liver biopsy specimens of three cases of BBs Ag positive chronic aggressive
hepatitis (Type 2B) (11) and three cases of the same type of HBs Ag negative
chronic aggressive hepatitis were also studied. BBs Ag in the sera was tested
by the reversed hemagglutination method (RPBA) (12).
Examination of the tissue localization of Clq was performed by the authors'
own technique (13, 14). Namely, saturated ammonium sulphate in 2% para-
formaldehyde solution (para-formaldehyde dissolved in water to a final con-
centration of 2% then saturated with ammonium sulphate) was cooled to 4°C,
and the resulting solution was applied for three minutes to fix tissue specimens.
Specimens fixed by this technique were compared with acetone-fixed and un-
fixed specimens. All specimens were then stained with fluorescein isothiocy-
anate (FITC)-labelled anti-human Clq solution (Behringwerke Laboratory) by
the direct immunofluorescent technique (15). The specificity of individual
stainings was checked by standard blocking tests (15).
At the same time, FITC-labelled anti-human IgG, IgA, and IgM reagents
(Behringwerke Laboratory) were also used by the same technique as that for
FITC-labelled anti-human C3 and C4 reagents (Dakopats Laboratory).
RESULTS
Fixation by 2% para-formaldehyde proved extremely effective. The locali-
zatibn of Clq was thus studied using this fixation in various tissues obtained from
the hepatocellular carcinoma autopsy case and for liver tissues of the six cases
with chronic hepatitis.
Clq localizations in various tissues of the autopsy case
Liver. Clq was found with weak fluorescence in the intra-hepatic connective
tissue and the cytoplasm of fibroblasts in portal triad. Moreover, Clq was local-
ized in either a diffuse or granular pattern on the surface of the membrane of
infiltrating lymphocytes in necrotic regions (Fig. I). Furthermore, in some
portal areas with exudation and hepatocellular necrosis, Clq was strongly de-
monstrated as an aggregation and/or an immune-like deposit. In these immune-
like deposit areas, C3, C4, IgG and IgM were also found.
Kidney. Clq was less obvious than IgG in the region of the glomerulus, but
was found in an identical degree to IgG as an immune-like local deposit in the
region of the glomerular epithelial cells (Fig. 2-a). C3 and C4 were also identified
in the same sites. Clq also was found in interstitial areas, being especially
marked in the connective tissues of the distal tubule region. The distribution
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Fig. 1. Autopsy liver specimens from a patient with hepatocellular carcinoma. Fig.la.
Clq was found in the collagen fibers and the cytoplasm of fibroblasts in connective tissue. An
immune deposit-like substance was;also localizedin-'some places of the interstitial tissue.
x 160. Fig. lb. Localization of C4 in the cytoplasm of carcinoma cells. X 160.
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Fig. 2. Kidney and spleen specimens of the patient with hepatocellular carcinoma.
Fig.2a. Clq in the region of the glomerulus of the kidney. An immune deposit-like sub-
stance is localized to the region of the glomerular epithelial cells. X 160. Fig.2b. Clq is
localized to the spaces between the central portion of the lymph follicles of the spleen. X 160.
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Fig. 3. Mesenterial lymph node of the same patient. Fig. 3a. Clq is distinctly more
pronounced than in the spleen. Clq is demonstrated at the membrane surface of lympho-
cytes and in the connective tissue trabecule. X 160. Fig.3b. Lymphocytes with Clq. X 400.
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Fig. 4. Clq in the stomach wall of the patient with hepatocellular carcinoma. Clq is
demonstrated in the interstitial tissue around the region of the fundal gland. X 160.
Fig. 5. Clq in the biopsy liver specimen from a patient with chronic aggressive hepa-
titis type B. Clq is demonstrated in the connective tissue and on the membrane of infiltrated
lymphocytes in portal triad. X 160.
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was more prominent in the walls of veins than in the arteries.
Spleen. Clq was detected in the spaces between the lymphocytes of the
small splenic nodes, viz., the central portion of the lymph follicles (Fig. 2-b).
Other sites included the membrane surface of peripheral lymphocytes, and a
weak fluorescence was present throughout the connective tissue trabeculae.
Lymph nodes. The localization of Clq was demonstrated within lymph
glands more distinctly than in the spleen (Fig. 3-a). Strong localization was ob-
served at the membrane surface of lymphocytes, being particularly marked in
cell groups that extended from the lymph follicle to the medulla (Fig. 3-b). Clq
was also demonstrated in the connective tissue trabeculae.
Stomach. In comparison with other organs, the presence of Clq was vivid in
the stomach wall, especially in the interstitial tissues around the fundal glands
(Fig. 4). Clq appeared in "pooling" in the spaces around the gland cells but was
not localized within the gland cells.
Small intestine. Similar localization was demonstrated in the intestinal con-
nective tissue but was extremely poor in comparison to the stomach wall.
Clq was localized on the membrane surface of small and medium sized lym-
phocytes in the connective tissues of all the organs. Clq-positive smalllympho-
cytes were found at the rate (per 100 small lymphocytes) of 1O~15 in lymph
nodes, 3-4 in the spleen, and 1-3 in the liver.
Clq-positive small lymphocytes predominated in the lymph nodes but the
coexistence of C3 and C4 was hardly demonstrated in sites outside the liver.
Clq localization in biopsy liver specimens of chronic hepatitis
The localization of Clq in the liver was found in the same pattern as that
described in the liver tissue of the autopsy case. Comparisons of Clq in the liver
tissues of the three cases with HBs Ag positive chronic aggressive hepatitis and
in the three cases with HBs Ag negative chronic aggressive hepatitis showed a
predominance of Clq in the former due to pronounced aggregation and/or im-
mune deposit-like localization (Fig. 5).
DISCUSSION
It is known that in the presence of Ca2 +, Clq (subcomponent of the first
component of complement) as CI in a trimolecular complex with Clr and CIs
(16), initially combines with the immune complex of antigen and with IgG or
IgM antibody in the classical pathway (17). Stroud et al. (18~20) have recently
reported that their experiments on the composition of this subcomponent have
shown it to be a protein resembling the collagen of connective tissues.
Thorbecke and others (21-24) reported the biosynthesis of Clq in vitro by
human and monkey liver, spleen, bone marrow, and lung, and furthermore in
macrophages isolated from peritoneal exudates and from lung washings. Their
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conclusions were based on the detection of radiolabelled Clq precipitin lines de-
veloping with an anti-Clq antiserum in the presence of carrier serum or euglo-
bulin. Colten et at. (25) also investigated Clq synthesis by a hemolytic plaque
method. Although the cellular site of Clq synthesis was not identified, these
workers suggested that since non-intestinal tissue, particularly those rich in
lymphoid cells also produced Clq, a mesenchymal cell and not an epithelial cell
was probably the site of synthesis. But renewed interest in the epithelial cell as
a site of Clq synthesis has been generated by the experiments of Bing, Spurlocke
and Bery (26). They demonstrated synthesis of macromolecular CI and CIs in
long-term primary suspension cultures of normal human colon, adenocarcinoma
of the colon, and transitional epithelial cells of the bladder and urethra. It is
obvious, therefore, that the definitive site of Clq synthesis is still a moot point in
question.
The present results using a modified fixation technique clearly help to clar-
ify the issue of the tissue localization of Clq. In regard to localization of Clq in
liver tissue of chronic hepatitis type B, HBs antigen-antibody-immune complexes
have been demonstrated in the serum of HBs Ag positive hepatitis (27), and it
thus indicates that Clq is richly localized in liver tissue. The present results,
however, showed no great difference between HBs Ag positive and negative
hepatitis. An interesting finding was the marked immune-like deposit localiza-
tion of Clq, especially in the HBs Ag positive cases. It is not possible to formu-
late a clear explanation of the localization of Clq, but the present work provides
some important guidelines for further study, particularly in regard to the patho-
genesis of chronic hepatitis.
REFERENCES
1. Yonemasu, K. and Stroud, R. M.: Clq: Rapid purification method for preparation of
monospecific antisera and fer biochemical studies. ]. Immunol. 106, 304-313, 1971.
2. Sobel, A., Bokisch, V. A. and Milller-Ebcrhard, H, J.: C1q deviation test for the detec-
tion of immune complexes, aggregates of IgG, and bacterial products in human serum.
j. Exp. Med. 142, 139-150, 1975.
3. Svehag, S.-E. and Burger, D.; Isolation of C1q-binding immune complexes by affinity
chromatography and desorption with a diaminoa1ky1 compound. Acta Pathol. Microbiol.
Scand., Sect. C 84, 45-52, 1976.
4. Zub1er, R.H., Lange, G., Lambert, P.H. and Miescher, P.A.: Detection of immune
complexes in unheated sera by a modified 1251 C1q binding test. Effect of heating on the
binding of C1q by immune complexes and application of the test to systemic lupus ery-
thematous. ]. Immunol. 116, 232--235, 1976.
5. Casali, P., Borzini, P. and Zanussi, C.: Immune complexes in myasthenia gravis. Lancet
ii, 378, 1976.
6. Blumberg, B. S.: Polymorph isms of the serum proteins and the development of iso-
precipitins in transfused patients. Bull. N.Y. Acad. Med. 40, 377-386, 1964.
7. Dudley, F. j., Fox, R. A. and Sherlock, S.: Relationship of hepatitis-associated antigen
(H.A. A.l to acute and chronic liver injury. Lancet ii, 1-3, 1971.
8
Acta Medica Okayama, Vol. 31 [1977], Iss. 1, Art. 7
http://escholarship.lib.okayama-u.ac.jp/amo/vol31/iss1/7
Localization of Clq in BBs Ag PositIve Patients 89
8. Tsuji, T., Naito, K., Nozaki, K. and Kosaka, K.: Simple assay of Australia antigen by
single radial immunodiffusion method and liver injury- Brief note. Acta Med. Okayama
26,5760, 1972.
9. Eddleston, A. L. W. F. and Williams, R.: Inadequate antibody response to HB Ag or
suppressor T-cell defect in development of active chronic hepatitis. Lancet ii, 1543-
1545, 1974.
10. Pesendorfer, F., Krassunitzky, O. and Wewalka, F.: Immunoelectrophoretischer Nach-
weis von" hepatitis-associated-antigen" (Au/SH antigen). Klin. Wsch. 48, 58-59, 1970.
II. De Groote, j., Desmet, V. j., Gedigk, P., Korb, G., Popper, H., Poulsen, H., Scheuer,
P. J., Schmid, M., Thaler, H., Uehlinger, E. and Wepler, W.: A classification of chronic
hepatitis. Lancet ir, 626-628, 1968.
12. Schuurs, A.H. W.M. and Ka~aki, J.: Reversed haemagglutination test for the detection
of hepatitis B antigen. Vox Sang. 27,97-114, 1974.
13. Tsuji, T., Tokuyama, K., Naito, K., Okazaki, S., Shinohara, T., Araki, K., Okada, T.,
Nozaki, H. and Nagashima, H.: A case report of hepatocellular carcinoma with pro-
longed HB virus infection and mono-clonal gammopathy. Gastroenterol. lpn. 1977 (in
press) .
14. Tsuji, T., Nozaki, H. and Naito, K.: The liver and complements. In Liver Disorder with
Immunological Aspect, ed. T. Kuroyanagi, Y. Otaka and T. Matsuhashi, Igaku Shoin, Ltd.,
Tokyo, pp. 183-211, 1973 (in Japanese).
15. Tsuji, T., Ogawa, K. and Kosaka, K.: An immunofluorescent study of circulating anti-
liver antibodies in chronic liver diseases. Acta Pathol. lpn. 15,273-286, 1965.
16. Lepow, 1. H., Naff, G. B., Todd, E. W, Pensky, J. and Hinz, C. F.: Chromatographic re-
solution of the first component of human complement into three activities. j. Exp. Med.
117, 987-1008, 1963.
17. Mayer, M. M.: The complement system. Sci. Am. 229, 54-66, 1973.
18. Stroud, R. M., Nagaki, K., Pickering, R. j., Gewurz, H., Good, R. A. and Cooper, M. D.:
Sub-units of the first complement component in immunologic deficiency syndoromes: In-
dependence of Cis and Clq. Glin. Exp. Immunol. 7,133-137. 1970.
19. Reid, K. B. M.: A collagen-like amino acid sequence in a polypeptide chain of human
Clq (a subcomponent of the first component of complement). Biochem. j. 141, 189-203,
1974.
20. Reid, K. B. M. and Porter, R. R.: Subunit composition and structure of subcomponent
Clq of the first component of human complement. Biochem. j. 155, 19-23, 1976.
21. Stecher, V. J. and Thorbecke, G. J.: Sites of synthesis of serum proteins. I. Serum
proteins produced by macrophages in vitro. j. Immunol. 99, 643-6~2, 1967.
22. Stecher, V.j., Morse, J. H. and Thorbecke, G.J.: Sites of production of primate serum
proteins associated with complement system. Proc. Soc. Exp. Biol. Med.124, 433-438, 1967.
23. Lai A Fat, R. F. M. and van Furth, R.: In vitro synthesis of some complement compo-
nents (Clq, C3 and C4) by lymphoid tissues and circulating leucocytes in man. Immuno-
logy 28, 359-368, 1975.
24. Day, N. K., Gewurz, H., Pickering, R. J. and Good, R. A.: Ontogenetic development of
Clq synthesis in the piglet. l. lmmunol. 104, 1316-1319, 1970.
25. Colten, H. R., Gorden, J. M., Borson, T. and Rapp, H. J.: Synthesis of the first compo-
nent of human complement in vitro. j. Exp. Med. 128, 595-604, 1968.
26. Bing, D. H., Spurlocke, S. E. and Bern, M. M.: Synthesis of the first component of com-
plement by primary cultures of human tumors of the colon and urogenital tract and
comparable normal tissue. Clin. Immunol. fmmunopathol. 4, 341-351, 1975.
27. Simons, M. j., Yu, M. and Shanmugaratnam, K.: Immunodeficiency to hepatitis B virus
infection and genetic susceptibility to development of hepatocellular carcinoma. Ann.
N. Y. Acad. Sci. 259, 181-195, 1975.
9
Tsuji et al.: Tissue localization of C1q in HBs antigen positive liver disease
Produced by The Berkeley Electronic Press, 1977
